International Symposium on Oncology, Immunotherapy and Biomarkers - (ISOIB-27)


6th - 7th April, 2027 | Helsinki, Finland

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

7th March, 2027

Paper Submission Deadline

12th March, 2027

Last Date Of Registration

22nd March, 2027

Date Of Conference

6th - 7th April, 2027

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ISOIB-27) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Oncology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Biomarkers in cancer diagnosis and treatment
  • Immunotherapy and its clinical applications
  • Role of precision medicine in oncology
  • Emerging trends in cancer immunotherapy
  • Biomarker discovery and validation
  • Challenges in immunotherapy implementation
  • Patient selection for immunotherapy
  • Combination therapies with immunotherapy
  • Ethical issues in biomarker research
  • Impact of biomarkers on treatment outcomes
  • Innovative technologies in biomarker analysis
  • Clinical trials for immunotherapeutic agents
  • Role of the immune system in cancer
  • Biomarkers for early cancer detection
  • Patient perspectives on immunotherapy
  • Regulatory considerations for biomarker use
  • Future directions in immunotherapy research
  • Collaboration between academia and industry
  • Health disparities in access to immunotherapy
  • Integrating biomarkers into clinical practice

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot